We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Sunday
May 08
14:15 - 15:30
Room D3
ESTRO-EORTC: Oligometastatic Disease
Morten Høyer, Denmark;
Piet Ost, Belgium
2370
Joint Symposium
Clinical
14:15 - 14:33
Countability rather than number of metastases to select patients for local ablative therapies (LAT) in oligometastatic disease and novel endpoints for trials and registries.
Joachim Widder, Austria
SP-0517
14:33 - 15:51
“It takes more than one course of local ablative radiotherapy in in oligometastatic cancer patients”: challenges and opportunities of repeat LAT and combination with systemic therapy
Marta Scorsetti, Italy
SP-0518
14:51 - 15:09
Registry trials for oligometastatic disease: rational and current status of the E2R OligoCare project
Piet Ost, Belgium
SP-0519
15:09 - 15:27
Going beyond clinical trials in the era of real world data
Catherine Fortpied, Belgium
SP-0520